DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



[Comparing effect in the management of erectile dysfunction by using 2 sets of drugs of intracavernosal injection]

Author(s): Jian HY, Hao JC

Affiliation(s): Medical Service Center of Family Planning of Hanzhong District, Hanzhong, Shan'xi 723000, China.

Publication date & source: 2003-06, Zhonghua Nan Ke Xue., 9(3):200-1.

Publication type: Clinical Trial; Comparative Study; English Abstract; Randomized Controlled Trial

OBJECTIVES: To supply clinical data for drug selextion in the treatment of erectile dysfunction through intracavernosal injection. METHODS: Fifty-six ED patients were randomly classified into 2 groups and received phentolamine along with papaverine (for group 1) or phentolamine, papaverine and ligustrazin hydrochloride(for group 2). RESULTS: Patients in group 2 enjoyed a longer time of erection. More patients in group 2 succeeded in having enough erection time and hardness to complete sexual intercourse (P < 0.05). CONCLUSIONS: The extrainjection of ligustrazin hydrochloride injection can help prolong erection duration and hardness and reduce tubercles that might occur in the corpus carvernosal. Therefore it is a safe and inexpensive drug in the intracarvernous injection treatment.

Page last updated: 2008-08-10

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017